Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 8NIH 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 11Breast Neoplasms, Male 2Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasm Female 1Breast Carcinoma In Situ 1

Interventions

Tamoxifen 3Radiotherapy 3Magnetic Resonance Spectroscopy 2Chemotherapy, Adjuvant 2Steroids 1Risedronic Acid 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Pharmacogenomic Testing 1Medroxyprogesterone 1Gene Expression Profiling 1Cholecalciferol 1Brachytherapy 1Anastrozole 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Carcinoma, Intraductal, Noninfiltrating × Anastrozole × Clear all
NCT00053898 2018-09-20

Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

NSABP Foundation Inc

Phase 3 Completed
3,104 enrolled 16 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡